Myoma - 123 Studies Found
Recruiting |
: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer :
: 2010-05-25 :
|
Completed |
: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin :
|
Completed |
: Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent :
|
Recruiting |
: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma :
|
Completed |
: A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) :
: |
Active, not recruiting |
: French National Registry of Rare Peritoneal Surface Malignancies :
|
Recruiting |
: Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) : Lymphangioleiomyomatosis : 2006-12-20 :
|
Completed |
: Pulmonary Rehabilitation in Lymphangioleiomyomatosis : Lymphangioleiomyomatosis : 2013-12-04 : Other: Pulmonary Rehabilitation |
Completed |
: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) : Pulmonary Lymphangioleiomyomatosis : 2014-04-15 : Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont |